trial,pubID,pseudogroup,weeks,group,IgD-IgM-/IgA-/IgG+ B cells
G002,G002-611,2.0,8,4,1907953.0
G002,G002-710,2.0,8,4,1004470.0
G002,G002-831,1.0,8,2,547910.0
G002,G002-387,2.0,8,4,1280712.0
G002,G002-136,1.0,8,2,1125353.0
G002,G002-365,2.0,8,4,1878438.0
G002,G002-145,1.0,8,2,835084.0
G002,G002-396,2.0,8,4,1305201.0
G002,G002-630,1.0,8,2,1952429.0
G002,G002-794,2.0,8,4,1184552.0
G002,G002-855,1.0,8,2,1187554.0
G002,G002-104,2.0,8,4,697937.0
G002,G002-947,1.0,8,2,465308.0
G002,G002-820,1.0,8,2,1122803.0
G002,G002-293,1.0,8,2,829012.0
G002,G002-119,1.0,8,2,797157.0
G002,G002-943,1.0,8,2,533230.0
G002,G002-230,1.0,8,2,2207617.0
G002,G002-957,1.0,8,2,602805.0
G002,G002-577,1.0,8,2,602391.0
G002,G002-480,1.0,8,2,688384.0
G002,G002-341,1.0,8,2,689328.0
G002,G002-493,1.0,8,2,174167.0
G002,G002-620,1.0,8,2,414478.0
